Showing results (121-130 of 200) with videos related to
Sort By:
Pageof 20
Cell Cycle (Georgetown, Tex.)|March 31, 2016
The WEE1 regulators CPEB1 and miR-15b switch from inhibitor to activators at G2/MGueorgui Kratassiouk, Linda L Pritchard, Sylvain Cuvellier, et al.Plos One|November 5, 2014
High efficiency ex vivo cloning of antigen-specific human effector T cellsMichelle A Neller, Michael H-L Lai, Catherine M Lanagan, et al.Nucleic Acids Research|September 1, 1997
Recruitment of transcription factors to the target site by triplex-forming oligonucleotidesF Svinarchuk, I Nagibneva, D Cherny, et al.Frontiers in Cardiovascular Medicine|February 22, 2021
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory SystemJacob Roberts, Antonia L Pritchard, Andrew T Treweeke, et al.Blood|November 5, 1997
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cellsS Taga, K Carlier, Z Mishal, et al.Kidney International|October 3, 1999
Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissueA C Ong, P C Harris, D R Davies, et al.Journal De La Societe De Biologie|June 6, 2008
[Micro-RNAs and muscle differentiation]Irina Naguibneva, Anna Polesskaya, Maya Ameyar-Zazoua, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 12, 2006
An LNA-based loss-of-function assay for micro-RNAsI Naguibneva, M Ameyar-Zazoua, N Nonne, et al.Cancer Immunology Research|June 7, 2015
Exome Sequencing to Predict Neoantigens in MelanomaAntonia L Pritchard, Julie G Burel, Michelle A Neller, et al.Journal of Pediatric Hematology/Oncology|March 1, 1997
Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?E R Lawlor, R A Anderson, J H Davis, et al.Pageof 20